[A case of advanced gastric cancer successfully treated by UFT and CDDP followed by surgical resection proving cancer cell disappearance in the stomach]. 1998

M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
Dept. of Surgery, Inabe Kosei Hospital.

A patient with advanced gastric cancer responded remarkably to UFT combined with CDDP. UFT was administered orally for 28 consecutive days at a dose of 400 mg/m2, and CDDP was injected intravenously for a day at a dose of 100 mg/m2. Surgical resection proved the histological disappearance of cancer cells in stomach.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
July 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
January 1989, Gan no rinsho. Japan journal of cancer clinics,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
October 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
August 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
June 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
November 2014, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
November 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
September 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
September 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
M Muramoto, and K Matsugaki, and K Ogino, and M Azuma, and A Inukai, and M Akao, and T Nakai, and T Manabe
November 2012, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!